EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiation Therapy

Razan Hessenow, Johann Matschke, Emil Mladenov, Xixi Lin, Feline Heinzelmann, Johannes Nikolas Esser, Sarah Etemadi Afshar, Fanghua Li, Aashish Soni, Christian Möllers, Maike Busch, Nicole Dünker und 6 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026

DOI: 10.1016/j.ijrobp.2026.02.234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Razan Hessenow und 17 weiteren Autor:innen. Beteiligte Einrichtung: West German Proton Therapy Centre Essen (WPE), University Hospital Essen, Essen, Germany; Institute of Cell Biology (Cancer Research), University Hos…. Hauptthemen laut MEDLINE: Radiation Tolerance, DNA Breaks, Double-Stranded, Proton Therapy, Homologous Recombination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Bundesministerium für Forschung, Technologie und Raumfahrt, Deutscher Akademischer Austauschdienst.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Proton beam radiation therapy (PBT) offers superior accuracy of dose deposition, reducing the risk of adverse effects to surrounding healthy tissues. However, despite high medical need, molecular and cellular determinants of radiosensitivity to PBT remain underexplored, and prognostic biomarkers and therapeutic targets informing precision medicine strategies for PBT are mostly missing. This study aimed to investigate the role of DNA double-strand break (DSB) repair pathways in shaping tumor response to proton versus photon radiation. METHODS AND MATERIALS: The study employed genetic and pharmacologic methods to impair DSB repair, including CRISPR-Cas9 gene editing to generate DSB repair deficient (ATM, PARP1, and BRCA2 knockout) A549 and HCT116 cell lines, and pharmacologic inhibitors of ATM and PARP using KU55933 or AZD1390 and olaparib, respectively. Cellular responses to photon (x-rays) and proton irradiation were evaluated through clonogenic survival assays, crystal violet proliferation, and annexin V/7AAD apoptosis assays. To investigate DNA repair mechanisms, U2OS reporter systems were employed, complemented by chromosomal aberration analysis, and pulsed-field gel electrophoresis. Finally, the translational relevance of the findings was validated using the chorioallantoic membrane assay closer representing an in vivo situation. RESULTS: PBT triggered a stronger activation of resection-dependent DNA repair pathways, primarily homologous recombination and alternative end-joining (alt-EJ), compared with photon irradiation. This increased activation was further supported by classical cytogenetics results. Tumor cells deficient in BRCA2, ATM, or PARP1 showed significantly increased sensitivity to PBT, highlighting enhanced relative biological effectiveness in both, in vitro and in the chorioallantoic membrane model. Importantly, combining PBT with olaparib, AZD1390 or KU55933 potentiated tumor cell killing, even in repair-proficient models, showing synergy not observed with photons. CONCLUSIONS: The observed genotype-specific or drug-induced increase in radiosensitivity toward PBT highlights the promise of genetic profiling of DSB repair defects for biology-driven patient stratification and the use of PARP inhibitors in guiding personalized proton radiation therapy strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation ToleranceDNA Breaks, Double-StrandedProton TherapyHomologous RecombinationDNA End-Joining RepairRecombinational DNA RepairHumansPhthalazinesCell Line, TumorPiperazinesPhotonsPoly (ADP-Ribose) Polymerase-1Ataxia Telangiectasia Mutated ProteinsApoptosisPoly(ADP-ribose) Polymerase InhibitorsBRCA2 Protein

Substanzen

PhthalazinesolaparibPiperazinesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Ataxia Telangiectasia Mutated ProteinsPoly(ADP-ribose) Polymerase InhibitorsATM protein, humanBRCA2 Protein

Autor:innen und Institutionen

  • West German Proton Therapy Centre Essen (WPE), University Hospital Essen, Essen, Germany; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK) partner site Essen a partnership between DKFZ and University Hospital…
  • Division of Experimental Radiation Biology, Department of Radiation Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • West German Proton Therapy Centre Essen (WPE), University Hospital Essen, Essen, Germany; West German Cancer Center WTZ, University Hospital Essen, Essen, Germany; Department of Physics, TU Dortmund University, Dortmund…
  • West German Proton Therapy Centre Essen (WPE), University Hospital Essen, Essen, Germany; West German Cancer Center WTZ, University Hospital Essen, Essen, Germany; Department of Particle Therapy, University Hospital Ess…
  • Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • Deutscher Akademischer Austauschdienst
  • Horizon 2020 Framework Programme
  • EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
  • Wilhelm Sander Foundation
  • Bundesministerium für Wirtschaft und Klimaschutz

Zitieren

APA

Hessenow, R., Matschke, J., Mladenov, E., Lin, X., Heinzelmann, F., Esser, J. N., Afshar, S. E., Li, F., Soni, A., Möllers, C., Busch, M., Dünker, N., Pantelias, G., Bäumer, C., Stuschke, M., Iliakis, G., Timmermann, B., & Jendrossek, V. (2026). Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.02.234

Vancouver

Hessenow R, Matschke J, Mladenov E, Lin X, Heinzelmann F, Esser JN, et al. Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.02.234

BibTeX
@article{Hessenow2026,
  author = {Hessenow, Razan and Matschke, Johann and Mladenov, Emil and Lin, Xixi and Heinzelmann, Feline and Esser, Johannes Nikolas and Afshar, Sarah Etemadi and Li, Fanghua and Soni, Aashish and Möllers, Christian and Busch, Maike and Dünker, Nicole and Pantelias, Gabriel and Bäumer, Christian and Stuschke, Martin and Iliakis, George and Timmermann, Beate and Jendrossek, Verena},
  title = {Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiation Therapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2026.02.234}
}
Kostenlos starten →